Last reviewed · How we verify
Furosemide first, then Acetazolamide — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Furosemide first, then Acetazolamide (Furosemide first, then Acetazolamide) — Rabin Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Furosemide first, then Acetazolamide TARGET | Furosemide first, then Acetazolamide | Rabin Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Furosemide first, then Acetazolamide CI watch — RSS
- Furosemide first, then Acetazolamide CI watch — Atom
- Furosemide first, then Acetazolamide CI watch — JSON
- Furosemide first, then Acetazolamide alone — RSS
Cite this brief
Drug Landscape (2026). Furosemide first, then Acetazolamide — Competitive Intelligence Brief. https://druglandscape.com/ci/furosemide-first-then-acetazolamide. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing